NIH study links rare disease to higher healthcare costs

By Health IT Analytics
| October 26, 2021

In a retrospective study led by the National Institutes of Health’s National Center for Advancing Translation Sciences (NCATS), researchers provide evidence that individuals with rare diseases face significantly higher healthcare costs.

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...